12-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry

Autor: Hemal Mehta, Vuong Nguyen, Pierre-Henry Gabrielle, Mateusz Niedzwiecki, Adrian Hunt, Daniel Barthelmes, Samantha Fraser-Bell, Mark C Gillies, Jennifer J. Arnold, Martin Guillemin, Catherine Creuzot-Garcher, Ian L. McAllister

Publikováno v: Acta Ophthalmologica Scandinavica
Acta Ophthalmologica Scandinavica, Wiley-Blackwell, In press, 13 (10), pp.15014. ⟨10.1111/aos.15014⟩

International audience; PURPOSE: To compare 12-month treatment outcomes of eyes receiving aflibercept or ranibizumab for macular oedema secondary to central retinal vein occlusion (CRVO) in routine clinical practice. METHODS: 296 treatment-naïve eye

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::102140f282e90ea4a637fb0b22c73fab